Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
It does not cause dependence, does not interact with GLP-1 receptor agonists, and works through an osmotic mechanism rather than stimulating the colon directly
First, it helps further mitigate additional compounded products from hitting the market
11.8% Avg Body Weight Loss* 68 Week Phase 3 Trial 1x Weekly Injection 2026 Expected FDA Decision Coming Soon A novel amylin analogue offering a different approach to weight management
Knowing about these things helps people get ready for their treatment
Each pen is prepared for easy administration and smooth use
Why is medical supervision important with BPC-157
US$ 20.74
US$ 28.64
US$ 20.20
US$ 26.20
US$ 25.37
US$ 24.40
US$ 25.65
